GERN- pounding the table at $3.06 !
What a steal this stock is IMO. Even if you compare the present price with the average analysts at $5, it's cheap. Also, the stock was $3.75 last year at some point, way before the NDA, and the great news last Thursday from ADCOM(almost assuring FDA approval). I will admit, this stock is played with big time, but no way is it worth less than $5 at this point, and as I posted my target is $11 over the next year or so.